Drug Price Trends for FT CHILD ALL DAY ALLER

Average Pharmacy Cost for FT CHILD ALL DAY ALLER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT CHILD ALL DAY ALLER 1 MG/ML	70677-1236-01	0.03411	ML	2025-02-19
FT CHILD ALL DAY ALLER 1 MG/ML	70677-1236-01	0.03376	ML	2025-01-22
FT CHILD ALL DAY ALLER 1 MG/ML	70677-1236-01	0.03190	ML	2024-12-18
FT CHILD ALL DAY ALLER 1 MG/ML	70677-1236-01	0.03194	ML	2024-11-20

Market Analysis and Price Projections for Children's Allergy Medications: A Focus on FT CHILD ALL DAY ALLER

Introduction to Children's Allergy Medications

The market for children's allergy medications is experiencing significant growth, driven by increasing prevalence of allergic conditions among children. This article will delve into the market analysis, price projections, and key factors influencing the demand for medications like FT CHILD ALL DAY ALLER.

Growing Prevalence of Allergies in Children

The incidence of allergies among children is on the rise, with environmental factors such as increased pollution, changing lifestyles, and urbanization contributing to this trend. According to the CDC, in 2021, 27.2% of children were diagnosed with at least one of the three main allergic conditions: seasonal allergies, eczema, or food allergies[1].

Market Size and Growth Projections

The global pediatric allergy diagnostics market, which includes the segment for allergy medications, is estimated to grow at a CAGR of 10.1% from 2024 to 2030, reaching USD 4.68 billion by 2030. This growth is driven by the increasing demand for diagnostic tests and effective therapeutic options[1].

Segment Analysis: Allergy Medications

Inhaled and Respiratory Allergies

The inhaled segment, which includes products like inhaled allergen challenge tests, held a significant share of the market in 2023. This segment is growing due to increasing awareness of respiratory allergies and advancements in inhaled diagnostic technologies. Asthma, for instance, is more prevalent among male children (7.0%) compared to female children (5.4%)[1].

Food Allergies

The food segment is expected to grow at a CAGR of 11.77% over the forecast period, driven by the rising incidence of food allergies among children. In the U.S., food allergies affect approximately 8% of children, which is a significant public health concern[1].

Diagnostic and Therapeutic Innovations

The market is witnessing robust product expansion driven by the development of innovative diagnostic tools and therapies. Companies are introducing advanced technologies such as component-resolved diagnostics, multiplex assays, and non-invasive testing methods to enhance accuracy and ease of use. These innovations are crucial for early detection and management of allergies in pediatric patients[1].

Pricing and Cost Considerations

Current Pricing

Medications like All Day Allergy Children's (cetirizine) are priced around $14 for a supply of 118 milliliters, depending on the pharmacy. Generic versions are also available, often at slightly higher prices, such as $19.16 for 118 milliliters[2].

Discount Programs and Patient Assistance

Discount cards and patient assistance programs can significantly reduce the cost of these medications. For example, the Drugs.com Discount Card can save consumers up to 80% or more off the cost of prescription medicines and over-the-counter drugs[2].

Consumer Preferences and Behavior

Brand vs. Store Brands

A significant portion of consumers believe that store brands and brand names offer the same quality. According to a survey, 72% of respondents said that brand names and store brands are usually the same quality, which influences their purchasing decisions[4].

Usage Patterns

Most households purchase over-the-counter seasonal allergy medication for adults, but a substantial percentage also buy for children. The survey found that 15% purchase for children aged 5-12, and 13% for teenage children aged 13-17[4].

Regional Market Analysis

North America

North America dominated the pediatric allergy diagnostics market with a share of 36.44% in 2023. This dominance is attributed to the rising incidence of allergies and supportive government initiatives. Early diagnosis and advancements in diagnostic technologies also contribute to this growth[1].

Europe

The pediatric allergy diagnostics market in Europe is experiencing significant growth due to the increasing prevalence of allergies. Over 150 million Europeans suffer from chronic allergic diseases, and projections indicate that by 2025, half of the EU population could be affected[1].

Future Market Trends

Technological Advancements

The market will continue to see advancements in diagnostic technologies, including multiplex assays and improved allergy panels. These innovations will enhance the accuracy and efficiency of tests, driving market expansion[1].

Increasing Awareness and Early Diagnosis

Growing awareness and early diagnosis of allergic conditions will further drive the demand for diagnostic tools and therapeutic options. This trend is expected to continue as healthcare systems focus on managing and mitigating the growing allergy burden[1].

Key Takeaways

• The global pediatric allergy diagnostics market is projected to grow at a CAGR of 10.1% from 2024 to 2030.
• The increasing prevalence of allergies among children, driven by environmental factors, is a key market driver.
• Innovations in diagnostic technologies and therapeutic options are enhancing market growth.
• Consumer preferences lean towards both brand and store brands, with a focus on quality and cost.
• Regional markets, particularly North America and Europe, are experiencing significant growth.

FAQs

What is the projected growth rate of the pediatric allergy diagnostics market?

The global pediatric allergy diagnostics market is projected to grow at a CAGR of 10.1% from 2024 to 2030[1].

How prevalent are allergies among children in the U.S.?

According to the CDC, in 2021, 27.2% of children were diagnosed with at least one of the three main allergic conditions: seasonal allergies, eczema, or food allergies[1].

What is the current pricing for children's allergy medications like All Day Allergy Children's?

The cost for All Day Allergy Children's (1 mg/mL) oral liquid is around $14 for a supply of 118 milliliters, depending on the pharmacy[2].

Do consumers prefer brand names or store brands for allergy medications?

72% of survey respondents believe that brand names and store brands offer the same quality, influencing their purchasing decisions[4].

How is the European market for pediatric allergy diagnostics performing?

The market in Europe is experiencing significant growth due to the increasing prevalence of allergies, with over 150 million Europeans suffering from chronic allergic diseases[1].

Sources

1. Grand View Research: "Pediatric Allergy Diagnostics Market Size, Share Report 2030"
2. Drugs.com: "All Day Allergy Children's Prices, Coupons, Copay Cards & Patient Assistance"
3. GlobeNewswire: "Allergy Treatment Market Size and Share Projected to Surpass USD 34.9 Billion by 2034 at 5.8% CAGR"
4. Numerator: "64% of U.S. Households Buy Seasonal Allergy Medication"